Timothy M.E. DavisWichai SupanaranondSasithon PukrittayakameeJuntra KarbwangPidist MoluntoSopon MekthonNicholas J. WhiteMahidol UniversityPaholpolpayuhasena HospitalJohn Radcliffe Hospital2018-06-142018-06-141990-01-01Journal of Infectious Diseases. Vol.161, No.6 (1990), 1305-130815376613002218992-s2.0-0025339526https://repository.li.mahidol.ac.th/handle/20.500.14594/16160Recommended initial treatment of severe chloroquine-resistant falciparum malaria consists of a 4-h loading infusion of20 mg of quinine dihydrochloride (salt)/kg of body weight. Toachieve and maintain therapeutic blood quinine concentrations (10mg/l) safely and rapidly, a consecutive-infusion regimen (7 mg of salt/kg of body weight over 30 min followed by 10 mg of salt/kg of body weight over 4 h) based on pharmacokinetic parameters in cerebral malaria has been suggested. This regimen was evaluated in 16 adults (6 male, 10 female; mean age, 25.9 years) with severe falciparum malaria. Plasma quinine concentrations (mean ± SE) were 8.7 ± 1.2 mg/l at 30 min and 11.0 ± 1.8mg/l at 4.5 h. There was no electrocardiographic evidence of serious cardiotoxicity during the 4.5-h infusion period, and systolic blood pressure fell by > 10 mm Hg in only one patient. Parasite clearance in 13 surviving patients (median count on admission, 438 * 10 3 /μl; range, 500-122 * 10 4 ) took an average of 71 h (range, 9-115). This regimen is safe, effective, and suitable for use in an intensive care unit. © 1990, University of Chicago. All rights reserved.Mahidol UniversityMedicineArticleSCOPUS10.1093/infdis/161.6.1305